MEDSIR is an international private company founded in 2012 by scientific experts in oncology. The company is dedicated to designing and managing strategic clinical trials in oncology, from the initial study conception to the final publication of results. MEDSIR acts as the link between its international network of brilliant oncology investigators and the parties interested in providing funding for their clinical research ideas, including Pharma Companies, Biotechs, Public Institutions, etc.
The company supports more than 200 ideas involving the most innovative drugs on the market and in development, optimizing every step of investigator-initiated research. MEDSIR's international team of high-level clinicians and research experts collaborates with top medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.
MEDSIR's slogan, "Bring Your Idea To Life 💡," resonates with its mission to transform promising concepts into strategic clinical trials that promote patient benefit, scientific advancement, and efficient drug development. The company is involved in the Marketing industry and has adapted to the General Data Protection Regulation, ensuring compliance with data privacy laws. For more information, interested parties can visit MEDSIR's website: www.medsir.org
Although specific details regarding the headquarter and last investment are not provided, MEDSIR's commitment to advancing oncology research and its collaboration with a diverse network of stakeholders position it as a potentially promising investment opportunity for venture capitalists seeking to support innovation in the healthcare and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for MEDSIR.